Literature DB >> 22674090

A new classification of positive sestamibi and ultrasound scans in parathyroid localization.

Orhan Agcaoglu1, Shamil Aliyev, Katy Heiden, Donald Neumann, Mira Milas, Jamie Mitchell, Allan E Siperstein, Eren Berber.   

Abstract

BACKGROUND: Ultrasound (US) and sestamibi (MIBI) are traditionally considered positive or negative. The purpose of this study was to define and test a new scoring system for MIBI and US and to determine whether this can improve their accuracy for primary hyperparathyroidism.
METHODS: This is a prospective study of 200 consecutive patients with primary hyperparathyroidism who had a single uptake on MIBI scans before bilateral neck exploration at a tertiary academic center between 2007 and 2008. These patients also had surgeon-performed neck US in the office, which was scored as "typical" or "atypical" based on how characteristic the image resembled a parathyroid gland. The MIBI uptake was scored by the nuclear medicine specialist as "weak," "moderate," or "strong" compared with the signal intensity of the thyroid. US and MIBI scoring was done preoperatively and their findings were compared with operative data.
RESULTS: Of 200 patients, 71 % had a single adenoma, 12 % had double adenomas, and 17 % had four-gland hyperplasia. A weak, moderate, and strong signal on MIBI had an accuracy of 23, 47, and 72 %, respectively, in demonstrating single-gland disease. An atypical versus typical US appearance was accurate in 55 and 74 % of the time, in identifying single-gland disease.
CONCLUSIONS: An appraisal of US and MIBI positivity in relation to image characteristics affects the reliability of both studies. This information should be kept in mind when selecting patients for focal neck exploration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22674090     DOI: 10.1007/s00268-012-1666-1

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  24 in total

1.  Initial neck exploration for untreated hyperparathyroidism.

Authors:  R C Martin; D Greenwell; M B Flynn
Journal:  Am Surg       Date:  2000-03       Impact factor: 0.688

2.  New point-of-care intraoperative parathyroid hormone assay for intraoperative guidance in parathyroidectomy.

Authors:  Denise M Carneiro; George L Irvin
Journal:  World J Surg       Date:  2002-05-21       Impact factor: 3.352

Review 3.  Biological factors influencing parathyroid localization.

Authors:  F Pons; J V Torregrosa; D Fuster
Journal:  Nucl Med Commun       Date:  2003-02       Impact factor: 1.690

4.  Values of ultrasonography, sestamibi scintigraphy, and intraoperative measurement of 1-84 PTH for unilateral neck exploration of primary hyperparathyroidism.

Authors:  Y Chapuis; Y Fulla; P Bonnichon; E Tarla; B Abboud; J Pitre; B Richard
Journal:  World J Surg       Date:  1996-09       Impact factor: 3.352

5.  Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience.

Authors:  Clive S Grant; Geoffrey Thompson; David Farley; Jon van Heerden
Journal:  Arch Surg       Date:  2005-05

6.  Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases.

Authors:  Allan Siperstein; Eren Berber; German F Barbosa; Michael Tsinberg; Andrew B Greene; Jamie Mitchell; Mira Milas
Journal:  Ann Surg       Date:  2008-09       Impact factor: 12.969

7.  5,000 parathyroid operations without frozen section or PTH assays: measuring individual parathyroid gland hormone production in real time.

Authors:  James Norman; Douglas Politz
Journal:  Ann Surg Oncol       Date:  2009-01-08       Impact factor: 5.344

8.  Long-term outcome of patients with elevated parathyroid hormone levels after successful parathyroidectomy for sporadic primary hyperparathyroidism.

Authors:  Carmen C Solorzano; William Mendez; John I Lew; Steven E Rodgers; Raquel Montano; Denise M Carneiro-Pla; George L Irvin
Journal:  Arch Surg       Date:  2008-07

9.  Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma.

Authors:  Mehmet Haciyanli; Geeta Lal; Eugene Morita; Quan-Yang Duh; Electron Kebebew; Orlo H Clark
Journal:  J Am Coll Surg       Date:  2003-11       Impact factor: 6.113

10.  Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas.

Authors:  Antonia E Stephen; Sanford I Roth; David W Fardo; Dianne M Finkelstein; Gregory W Randolph; Randall D Gaz; Richard A Hodin
Journal:  Arch Surg       Date:  2007-04
View more
  2 in total

1.  Is focused parathyroidectomy appropriate for patients with primary hyperparathyroidism?

Authors:  Won Woong Kim; Yumie Rhee; Eun Jeong Ban; Cho Rok Lee; Sang-Wook Kang; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung; Cheong Soo Park
Journal:  Ann Surg Treat Res       Date:  2016-08-29       Impact factor: 1.859

2.  Clinical usefulness of intraoperative parathyroid hormone monitoring for primary hyperparathyroidism.

Authors:  Se Hyun Paek; Su-Jin Kim; June Young Choi; Kyu Eun Lee
Journal:  Ann Surg Treat Res       Date:  2018-01-30       Impact factor: 1.859

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.